Texas Capital Bancshares, Inc. (TCBIO) — Analyst outlook / Analyst consensus target is. Based on 26 analyst ratings, the consensus is bullish — 1 Strong Buy, 6 Buy, 16 Hold, 3 Sell.
Analysts estimate Earnings Per Share (EPS) of $0.93 and revenue of $1.11B for the next fiscal year.
Earnings Per Share (EPS) track record: 2024: actual $2.05 vs est $0.93 (beat +120.2%). 2025: actual $6.87 vs est $6.46 (beat +6.4%). Analyst accuracy: 70%.
TCBIO Analyst Ratings
Hold
Based on 26 analysts giving stock ratings to Texas Capital Bancshares, Inc. in the past 3 months
EPS Estimates — TCBIO
70%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $2.05
vs Est $0.93
▲ 54.6% off
2025
Actual $6.87
vs Est $6.46
▲ 6.0% off
Profitability Outlook
Company is profitable with solid earnings. EPS trend is improving.
Revenue Estimates — TCBIO
63%
Analyst Accuracy
Fair
2 years compared
Actual vs Estimate
2024
Actual $1.761B
vs Est $1.112B
▲ 36.8% off
2025
Actual $1.999B
vs Est $1.253B
▲ 37.3% off
Revenue Trend
Moderate revenue growth trend. Analysts forecast revenue contraction ahead.
